352 related articles for article (PubMed ID: 25150707)
1. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
[TBL] [Abstract][Full Text] [Related]
2. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
[TBL] [Abstract][Full Text] [Related]
3. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
Srivastava NK; Yadav R; Mukherjee S; Sinha N
Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
[TBL] [Abstract][Full Text] [Related]
4. Serum miRNAs as biomarkers for the rare types of muscular dystrophy.
Koutsoulidou A; Koutalianos D; Georgiou K; Kakouri AC; Oulas A; Tomazou M; Kyriakides TC; Roos A; Papadimas GK; Papadopoulos C; Kararizou E; Spyrou GM; Zamba Papanicolaou E; Lochmüller H; Phylactou LA
Neuromuscul Disord; 2022 Apr; 32(4):332-346. PubMed ID: 35393236
[TBL] [Abstract][Full Text] [Related]
5. Digital PCR quantification of miR-30c and miR-181a as serum biomarkers for Duchenne muscular dystrophy.
Llano-Diez M; Ortez CI; Gay JA; Álvarez-Cabado L; Jou C; Medina J; Nascimento A; Jimenez-Mallebrera C
Neuromuscul Disord; 2017 Jan; 27(1):15-23. PubMed ID: 27979502
[TBL] [Abstract][Full Text] [Related]
6. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
[TBL] [Abstract][Full Text] [Related]
7. Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy.
Andersen SP; Sveen ML; Hansen RS; Madsen KL; Hansen JB; Madsen M; Vissing J
Muscle Nerve; 2013 Dec; 48(6):897-901. PubMed ID: 23512655
[TBL] [Abstract][Full Text] [Related]
8. Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.
Zaharieva IT; Calissano M; Scoto M; Preston M; Cirak S; Feng L; Collins J; Kole R; Guglieri M; Straub V; Bushby K; Ferlini A; Morgan JE; Muntoni F
PLoS One; 2013; 8(11):e80263. PubMed ID: 24282529
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy.
Spitali P; Hettne K; Tsonaka R; Sabir E; Seyer A; Hemerik JBA; Goeman JJ; Picillo E; Ergoli M; Politano L; Aartsma-Rus A
J Cell Mol Med; 2018 Apr; 22(4):2442-2448. PubMed ID: 29441734
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
[TBL] [Abstract][Full Text] [Related]
11. Metabolic status of patients with muscular dystrophy in early phase of the disease: In vitro, high resolution NMR spectroscopy based metabolomics analysis of serum.
Srivastava NK; Annarao S; Sinha N
Life Sci; 2016 Apr; 151():122-129. PubMed ID: 26930370
[TBL] [Abstract][Full Text] [Related]
12. Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy.
Zhang J; Meng Q; Zhong J; Zhang M; Qin X; Ni X; Ma J; He Y; Zeng D; Lan D
Front Neurol; 2020; 11():563609. PubMed ID: 33071947
[No Abstract] [Full Text] [Related]
13. Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis.
Leone E; Pandyan A; Rogers A; Kulshrestha R; Hill J; Philp F
J Neurol Neurosurg Psychiatry; 2024 Apr; 95(5):442-453. PubMed ID: 38124127
[TBL] [Abstract][Full Text] [Related]
14. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy.
Mizuno H; Nakamura A; Aoki Y; Ito N; Kishi S; Yamamoto K; Sekiguchi M; Takeda S; Hashido K
PLoS One; 2011 Mar; 6(3):e18388. PubMed ID: 21479190
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as serum biomarkers in Becker muscular dystrophy.
Gagliardi D; Rizzuti M; Brusa R; Ripolone M; Zanotti S; Minuti E; Parente V; Dioni L; Cazzaniga S; Bettica P; Bresolin N; Comi GP; Corti S; Magri F; Velardo D
J Cell Mol Med; 2022 Sep; 26(17):4678-4685. PubMed ID: 35880500
[TBL] [Abstract][Full Text] [Related]
16. An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy.
Zelikovich AS; Joslin BC; Casey P; McNally EM; Ajroud-Driss S
J Neuromuscul Dis; 2022; 9(2):275-287. PubMed ID: 35124660
[TBL] [Abstract][Full Text] [Related]
17. Decreased bone mineral density in adult patients with muscular dystrophy.
Philippe V; Pruna L; Abdel Fattah M; Pascal V; Kaminsky P
Joint Bone Spine; 2011 Dec; 78(6):651-2. PubMed ID: 21727019
[No Abstract] [Full Text] [Related]
18. Circulating MicroRNAs in Duchenne Muscular Dystrophy.
Mousa NO; Abdellatif A; Fahmy N; Zada S; El-Fawal H; Osman A
Clin Neurol Neurosurg; 2020 Feb; 189():105634. PubMed ID: 31838454
[TBL] [Abstract][Full Text] [Related]
19. Novel miRNA Biomarkers for Patients With Duchenne Muscular Dystrophy.
Meng Q; Zhang J; Zhong J; Zeng D; Lan D
Front Neurol; 2022; 13():921785. PubMed ID: 35873767
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders.
Mousa NO; Abdellatif A; Fahmy N; El-Fawal H; Osman A
Neuromolecular Med; 2023 Dec; 25(4):603-615. PubMed ID: 37856057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
